Keywords: amgen, anticipates, rise, its, spanish, sales, usa-based
Amgen anticipates rise in its Spanish sales
Article | 12 December 2005
USA-based biotechnology firm Amgen predicts that its sales in Spain will rise 10% to over 100.0 million euros ($117.9 million) in 2005, due to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
